Browsing Tag
Pulnovo Medical
2 posts
Pulnovo Medical secures dual IDE approvals with CMS backing to advance PADN clinical trials in the U.S.
Pulnovo Medical gains FDA IDE and CMS coverage to launch PADN U.S. trials, signaling disruption in the pulmonary hypertension device market.
Can PADN technology redefine treatment for pulmonary hypertension? Pulnovo’s trials begin in U.S.
Pulnovo Medical wins FDA IDE approvals and CMS backing for U.S. trials of its PADN system in pulmonary hypertension. Find out what this means for patients.